Literature DB >> 7482986

Use of an antagonist for estimating the degree of agonist stimulation during physiological release.

R B Barlow.   

Abstract

Antagonist activity can be measured either as the percentage reduction in the effect of an agonist or as a dose ratio. In this article, Dick Barlow explains how these are connected and how the relationship between the concentration of antagonist producing 50% inhibition (IC50) and the antagonist equilibrium constant (Ki) involves the degree of agonist stimulation ([A]/[A50]), which is the concentration of agonist expressed as a multiple of the concentration producing a half-maximal response. If Ki is known it is possible to use the IC50 value of the antagonist to estimate the degree of agonist stimulation in physiological experiments where there is neuronal or hormonal release of the agonist.

Mesh:

Substances:

Year:  1995        PMID: 7482986     DOI: 10.1016/s0165-6147(00)89042-2

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  3 in total

1.  A comparison of effects measured with isotonic and isometric recording: II. Concentration-effect curves for physiological antagonists.

Authors:  R B Barlow; S M Bond; C Grant; D S McQueen; Z Yaqoob
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

2.  Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices.

Authors:  S Latini; F Bordoni; F Pedata; R Corradetti
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

3.  Gamma-aminobutyric acid B receptor mediated inhibition of gonadotropin-releasing hormone neurons is suppressed by kisspeptin-G protein-coupled receptor 54 signaling.

Authors:  Chunguang Zhang; Martha A Bosch; Oline K Rønnekleiv; Martin J Kelly
Journal:  Endocrinology       Date:  2009-01-22       Impact factor: 4.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.